Prostamax 20mg

£44.90

Prostamax is a synthetic tetrapeptide used as a research tool to investigate tissue-specific gene-expression regulation in prostate-derived experimental systems.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC)
  • CAS Number: N/A
  • Molecular Formula: C20H33N5O9
  • Amino Acid Sequence: Lys-Glu-Asp-Pro (KEDP)

In stock

Add to Cart
Prostamax 20mg
Prostamax 20mg
£44.90
  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at ≥ 99% purity
  • Storage: –20 °C long term; 2–8 °C short term
  • Sold for research purposes only

Prostamax

Synonyms / Designations: Prostamax; KEDP; Lys-Glu-Asp-Pro; synthetic short peptide
Amino Acid Sequence: Lys-Glu-Asp-Pro (KEDP)
CAS Number: N/A
Molecular Formula: C20H33N5O9
Molecular Weight: 487.51 g/mol
Purity: ≥ 99% (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 20 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C or below
Solubility: Soluble in water and buffered aqueous solutions

Description & Mechanism

Prostamax (KEDP) is studied in vitro as a prostate-tissue-directed short-peptide probe, used to examine how a minimal defined peptide signal influences transcriptional, proteomic and proliferation/apoptosis endpoints in prostate-derived cell populations.

Peptides of this class are proposed to act at the chromatin level to modulate tissue-specific gene-expression patterns in experimental models. It is used as a comparator/tool compound for tissue-specificity studies; observed effects depend on concentration, model system and exposure conditions.

Applications in Research

  • In-vitro investigation of prostate-derived cell proliferation / apoptosis markers
  • Tissue-specificity comparison across related short peptides
  • Probe for short-peptide transcriptional regulation in genitourinary tissue

Specifications Summary

ParameterTypical Value / Range
Purity (HPLC)≥ 99%
AppearanceWhite to off-white lyophilised powder
Molecular Weight487.51 g/mol
Peptide TypeSynthetic tetrapeptide
SolubilityWater, buffered aqueous solutions
Storage–20 °C, desiccated, dark
Pack Size20 mg (total)

Precautions & Notes

  • Experimental behaviour is dependent on concentration, model system and exposure conditions
  • Appropriate experimental controls are recommended
  • Prolonged exposure to light, elevated temperature or aqueous environments may reduce stability
  • Intended strictly for laboratory research use; not for human or veterinary application

References

Khavinson VKh, Popovich IG, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053.
https://www.mdpi.com/1420-3049/26/22/7053

Keywords: Prostamax, KEDP, short peptide, synthetic tetrapeptide